factors impacting response to icis in muc
Published 3 years ago • 15 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
0:53
strategies to enhance anti-tumor t cell response to immune checkpoint inhibitors in tnbc
-
2:18
what factors affect response to checkpoint inhibitors in lung cancer?
-
2:47
does time from initiation of platinum-based chemotherapy to second-line icis affect outcomes in muc?
-
5:01
predicting long-term benefit from icis in muc
-
2:34
biomarkers of response to checkpoint inhibitors in untreated mnsclc
-
2:07
subtypes of egfr- and her2-mutant metastatic nsclc influence response to icis
-
1:08:33
stanford cancer institute breakthroughs in cancer: jennifer wargo, md, mmsc
-
1:01:54
"immune checkpoint blockade in cancer therapy" by dr. jim allison
-
1:19:04
can we starve cancer? what you need to know! | dr. thomas seyfried
-
1:02
challenges in identifying predictive markers to icis in triple-negative breast cancer
-
0:48
improving response to immune checkpoint blockade in cscc
-
2:12
dr. vokes on investigative biomarkers of response to checkpoint inhibitors in cancer
-
1:46
predicting response to checkpoint inhibitors and overcoming resistance in lung cancers
-
4:17
hevs and lymphocyte recruitment in tumors in response to immune checkpoint blockade
-
1:48
tissue specificity in immune responses when using checkpoint blockade immunotherapy to treat tumors
-
26:28
multi-omics analysis of the response to immune checkpoint inhibitors at single cell resolution
-
2:01
association between tmb and iraes during ici therapy in patients with muc
-
1:08
the tumor-myeloid axis as a predictor of response to immunotherapy in nsclc
-
0:45
breast cancer: maximizing response to checkpoint inhibitors
-
2:16
landscape analysis of neoepitope-specific t-cell responses depending on clinical benefit from icis
-
2:48
impact of prior antibiotic exposure on the outcomes of immune checkpoint inhibitor immunotherapy
-
3:23
cd8 t-cell receptor signatures of response to checkpoint immunotherapy